Literature DB >> 26170924

Caspase-3 inhibitor prevents the apoptosis of brain tissue in rats with acute cerebral infarction.

Yuhua Sun1, Yuming Xu2, Lijiao Geng3.   

Abstract

The aim of the present study was to investigate the effect of the caspase-3 inhibitor z-DEVD-fmk on the apoptosis of the brain tissues of rats with acute cerebral infarction. Middle cerebral artery occlusion was used to establish a rat model of infarction, and the rats were randomly divided into a sham group (n=15), model group (n=15) and treatment group (n=15). z-DEVD-fmk (2.5 µg/kg) was injected into the intracranial artery of rats in the treatment group, while the same volume of phosphate-buffered saline solution was administered to the rats of the sham and model groups. After 48 h, all rats were sacrificed and their brain tissues were removed. The caspase-3 mRNA level, protein level and activity, brain cell apoptosis index and infarction scope of the three groups were analyzed. Neurological impairment was also assessed. At 48 h after model establishment, the caspase-3 mRNA and protein levels in the brain tissues of the model group were significantly higher than those of the sham group, and those in the treatment group were significantly lower than those in the model group (P<0.05); however, they remained significantly higher than those in the sham group. Caspase-3 activity in the model group was significantly higher than that in the sham group, and treatment with the caspase-3 inhibitor significantly reduced caspase-3 activity compared with that in the model group (P<0.05). The apoptosis index and infarction scope in the model and treatment groups were significantly increased compared with those in the sham group, and were significantly lower in the treatment group than in the model group (P<0.05). The neurological impairment of rats in the model and treatment groups was increased significantly compared with that in the sham group, and the treatment group exhibited a significantly lower level of neurological impairment than the model group (P<0.05). In conclusion, the caspase-3 inhibitor z-DEVD-fmk effectively inhibited apoptosis and delayed the necrosis of brain tissue cells in rats with acute cerebral infarction, and had certain protective effects on brain tissue.

Entities:  

Keywords:  acute cerebral infarction; apoptosis; caspase-3 inhibitor

Year:  2015        PMID: 26170924      PMCID: PMC4487074          DOI: 10.3892/etm.2015.2462

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  20 in total

1.  [Effects of caspase-3 inhibitor on the neuronal apoptosis in rat cerebral cortex after ischemia-reperfusion injury].

Authors:  Shi-zhu Yu; Li Yan; Qian Wang; Tong-ling An; Xin-qin Guan
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2006-03

Review 2.  Apoptosis: a target for neuroprotection.

Authors:  Christiane Charriaut-Marlangue
Journal:  Therapie       Date:  2004 Mar-Apr       Impact factor: 2.070

3.  Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model.

Authors:  J A Oostveen; E Dunn; D B Carter; E D Hall
Journal:  J Cereb Blood Flow Metab       Date:  1998-05       Impact factor: 6.200

Review 4.  Caspase-3 as a therapeutic target for heart failure.

Authors:  Bo Yang; Dewei Ye; Yu Wang
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

5.  Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model.

Authors:  L Belayev; O F Alonso; R Busto; W Zhao; M D Ginsberg
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

6.  L-carnosine inhibits neuronal cell apoptosis through signal transducer and activator of transcription 3 signaling pathway after acute focal cerebral ischemia.

Authors:  Jian-Ping Wang; Zhi-Tang Yang; Cong Liu; Yuan-Hong He; Shan-Shan Zhao
Journal:  Brain Res       Date:  2013-02-27       Impact factor: 3.252

7.  Caspase-dependent and caspase-independent signalling of apoptosis in the penumbra following middle cerebral artery occlusion in the adult rat.

Authors:  I Ferrer; B Friguls; E Dalfó; C Justicia; A M Planas
Journal:  Neuropathol Appl Neurobiol       Date:  2003-10       Impact factor: 8.090

8.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

9.  Caspase-3 is related to infarct growth after human ischemic stroke.

Authors:  A Rosell; E Cuadrado; J Alvarez-Sabín; M Hernández-Guillamon; P Delgado; A Penalba; M Mendioroz; A Rovira; I Fernández-Cadenas; M Ribó; C A Molina; J Montaner
Journal:  Neurosci Lett       Date:  2007-05-06       Impact factor: 3.046

Review 10.  Acute cardioembolic cerebral infarction: answers to clinical questions.

Authors:  Adria Arboix; Josefina Alio
Journal:  Curr Cardiol Rev       Date:  2012-02
View more
  12 in total

1.  Neuroprotective effect of chlorogenic acid in global cerebral ischemia-reperfusion rat model.

Authors:  Gaurav Kumar; Sumedha Mukherjee; Pankaj Paliwal; Saumitra Sen Singh; Hareram Birla; Surya Pratap Singh; Sairam Krishnamurthy; Ranjana Patnaik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-12       Impact factor: 3.000

2.  Necroptotic-Apoptotic Regulation in an Endothelin-1 Model of Cerebral Ischemia.

Authors:  Chesarahmia Dojo Soeandy; Andrew J Elia; Yanshan Cao; Christopher Rodgers; Shudi Huang; Andrea C Elia; Jeffrey T Henderson
Journal:  Cell Mol Neurobiol       Date:  2020-08-25       Impact factor: 5.046

Review 3.  Different Roles of Mitochondria in Cell Death and Inflammation: Focusing on Mitochondrial Quality Control in Ischemic Stroke and Reperfusion.

Authors:  Marianna Carinci; Bianca Vezzani; Simone Patergnani; Peter Ludewig; Katrin Lessmann; Tim Magnus; Ilaria Casetta; Maura Pugliatti; Paolo Pinton; Carlotta Giorgi
Journal:  Biomedicines       Date:  2021-02-09

4.  Efficacy and Safety of Xueshuantong Injection on Acute Cerebral Infarction: Clinical Evidence and GRADE Assessment.

Authors:  Jian Lyu; Yanming Xie; Menghua Sun; Lidan Zhang
Journal:  Front Pharmacol       Date:  2020-07-02       Impact factor: 5.810

Review 5.  Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review.

Authors:  Neha Dhir; Bikash Medhi; Ajay Prakash; Manoj Kumar Goyal; Manish Modi; Sandeep Mohindra
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

6.  Effect of Comprehensive Cerebral Protection Program on Cerebral Oxygen Metabolism and Vascular Endothelial Function in Elderly Patients with Acute Cerebral Infarction.

Authors:  Meihong Zhou; Zhaojun Huang
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

7.  Immunopathology of Fatal Human Variegated Squirrel Bornavirus 1 Encephalitis, Germany, 2011-2013.

Authors:  Dennis Tappe; Jonas Schmidt-Chanasit; Jessica Rauch; Petra Allartz; Christiane Herden
Journal:  Emerg Infect Dis       Date:  2019-06       Impact factor: 6.883

Review 8.  Hypoxia Tolerant Species: The Wisdom of Nature Translated into Targets for Stroke Therapy.

Authors:  Carmen Del Río; Joan Montaner
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

9.  Allicin protects against H2O2-induced apoptosis of PC12 cells via the mitochondrial pathway.

Authors:  Runxiao Lv; Lili Du; Chunwen Lu; Jinhui Wu; Muchen Ding; Chao Wang; Ningfang Mao; Zhicai Shi
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

10.  Apoptosis in cerebrospinal fluid as outcome predictors in severe traumatic brain injury: An observational study.

Authors:  Wenqing Jiang; Peng Jin; Wenfeng Wei; Wei Jiang
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.